Covered recipient · General Payments record
ERIC M TATE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$2,200.85
- Reported across 74 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.77 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $181.70 | 5 |
| Acerta Pharma LLC | $71.52 | 3 |
| Merck Sharp & Dohme Corporation | $43.88 | 2 |
| ABIOMED | $31.80 | 1 |
| Lilly USA, LLC | $28.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $31.80 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174450970 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.40 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206291684 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.28 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206275320 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.84 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207076780 | CMS |
| Lilly USA, LLC | $28.87 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186587416 | CMS |
| Merck Sharp & Dohme LLC | $21.79 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238043483 | CMS |
| Merck Sharp & Dohme LLC | $22.09 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238230072 | CMS |
| Novo Nordisk Inc | $7.16 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188234893 | CMS |
| Novo Nordisk Inc | $20.05 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188412141 | CMS |
| Novo Nordisk Inc | $3.33 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188972743 | CMS |
| Novo Nordisk Inc | $26.15 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189029120 | CMS |
| Novo Nordisk Inc | $125.01 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188830446 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.